Epilepsy Talk
Treating Seizures — 7 Amazing New Breakthroughs
15 Comments
What if you could predict an oncoming seizure in time for you stop it? Or even prevent it?
That day may be coming sooner than you think, thanks to these seven new technologies.
You’ll learn what they are, how they work and how far along they are.
Hidden hospital bill gouging…gone!
5 Comments
In April 2017, a man named Drew Calver thought he was dying. A heart attack had pinned him to the floor of his bedroom. His neighbor took him to St. David’s Medical Center in Austin, where he was successfully treated.
Weeks later, he received a bill from the hospital: That’ll be $108,951.31, please. St. David’s was out of network on his insurance, and Aetna had only paid $55,840 of the total $164,941 bill for his treatment.
$56,000 a year for an unproven drug!
Leave a Comment
Getting the FDA to retract a decision, is like getting the toothpaste back in the tube, after it’s been squeezed out…
Whether it’s “yes” or “no,” there is no “maybe so”.
A good example is the new all star Alzheimer’s drug aducanumab.
Whether it’s “yes” or “no,” there is no “maybe so”.
Tags: $56000 a year, aducanumab, Alzheimer’s, efficiency, FDA, not proven, patients, risk, side-effects
A ‘Pacemaker’ for the Brain…Reducing Seizures by as Much as 50%…and Depression up to 30%
3 Comments
Some people know Deep Brain Stimulation (DBS) as a treatment for epilepsy, reducing seizures by as much as 50 percent.
It’s designed for the considerable number of patients suffering from medically refractory epilepsy who are not candidates for for resective brain surgery.
This tiny pacemaker-like device, is implanted in the brain to deliver a small amount of electricity when it detects the onset of a seizure.
But, what most people DON’T know know is that Deep Brain Stimulation, can help depression by up to 30 per cent.
Tags: can help depression by up to 30%, DBS, Deep Brain Stimulation, emotions, individualized, nearly 1/3 of the more than 250 million people with depression, one size does not fit all, pacemaker-like device, reducing seizures bu as much as 50%, tiny
What Is the FDA Thinking?
3 Comments
Getting the FDA to retract a decision is like getting the toothpaste back into the tube, once it’s been squeezed out.
Take the current all-star Alzheimer’s drug aducanumab. It’s not a proven but it IS approved. To the hefty price tag of $56,000 a year!
$112 billion new Alzheimer’s drug in question
4 Comments
Getting the FDA to retract a decision is like getting the toothpaste back in the tub, after it’s been squeezed out…
Whether it’s “yes” or “no,” there is no “maybe so”.
A good example is the new all star Alzheimer’s drug aducanumab.
Tags: $112 billion costs, &56000 a year, alzheimer's, FDA, Medicare, not proven, side effects
The first new Alzheimer’s drug in 18 years may not work.
Leave a Comment
Getting the FDA to retract a decision is like getting the toothpaste back in the tub, after it’s been squeezed out…
Whether it’s “yes” or “no,” there is no “maybe so”.
A good example is the new all-star Alzheimer’s drug aducanumab.
Tags: $5600 a year, aducanumab, Alzheimer's drug, amyloid plaque, billions of dollars, caregiver, FDA, Medicare, not proven
Marijuana has won…
22 Comments
In the span of two decades, marijuana legalization has gone from a fringe issue to one the vast majority of Americans embrace.
In 2000, just 31 percent of the country backed legalization while 64 percent opposed it, according to Gallup’s public surveys.
By 2020, the numbers flipped: The most recent Gallup poll on the topic showed that 68 percent supported legalization and 32 percent were against it.
Tags: Biden, legalization, majority of states, marijuana, politics, Trump
Medical Marijuana — It’s Here to Stay…
14 Comments
Let’s face it. The time has come.
Even the FDA has opened its eyes with new clinical trials.
Although the AMA chooses to keep their heads in the sand. For now.
It used to be popular to debate the merits and dangers of medical marijuana.
For example, it could lead to addiction. Like cocaine. (Oh please!)
But now, there’s clinically proven scientific proof, with more to come…
About the author
Epilepsy Talk 